Abstract
Metabolic disorders associated with abdominal obesity, dyslipidaemia, arterial hypertension and hyperglycaemia are risk factors to develop insulin resistance. Extracellular vesicles (EVs) may play an important role in regulation of metabolic signalling pathways in insulin resistance and associated complications.
Methods: Circulating large (lEVs) and small (sEVs) EVs from non-insulin resistant (n-IR) and insulin resistant (IR) patients were isolated and characterized. lEVs and sEVs were injected i.v. in mice and systemic, adipose tissue, and liver insulin signalling were analysed. The role of phosphatases PTP1B and PP2A were analysed on target tissues and cells.
Results: Injection of lEVs and sEVs from IR patients impaired systemic, adipose tissue, and liver insulin signalling in mice, while EVs from n-IR patients had no effect. Moreover, IR lEVs and IR sEVs increased two-fold adipocyte size and adipogenic gene expression. EVs from IR patients expressed two types of phosphatases, phosphotyrosine 1 phosphatase (PTP1B) and protein phosphatase 2 (PP2A), IR lEVs being enriched with the active form of PTP1B while IR sEVs mainly carried active PP2A. Blockade of PTP1B activity in IR lEVs fully restored IRS1 and AKT phosphorylation in adipocytes and blunted insulin-induced AKT phosphorylation by inhibition of macrophage secretome in hepatocytes. Conversely, blockade of PP2A activity in IR sEVs completely prevented insulin resistance in adipocytes and hepatocytes.
Conclusions: These data demonstrate that inhibition of phosphatases carried by EVs from IR patients rescues insulin signalling in adipocytes and hepatocytes and highlight PTP1B and PP2A carried by IR EVs as novel potential therapeutic targets against insulin resistance in adipose tissue and liver and the development of obesity.
Methods: Circulating large (lEVs) and small (sEVs) EVs from non-insulin resistant (n-IR) and insulin resistant (IR) patients were isolated and characterized. lEVs and sEVs were injected i.v. in mice and systemic, adipose tissue, and liver insulin signalling were analysed. The role of phosphatases PTP1B and PP2A were analysed on target tissues and cells.
Results: Injection of lEVs and sEVs from IR patients impaired systemic, adipose tissue, and liver insulin signalling in mice, while EVs from n-IR patients had no effect. Moreover, IR lEVs and IR sEVs increased two-fold adipocyte size and adipogenic gene expression. EVs from IR patients expressed two types of phosphatases, phosphotyrosine 1 phosphatase (PTP1B) and protein phosphatase 2 (PP2A), IR lEVs being enriched with the active form of PTP1B while IR sEVs mainly carried active PP2A. Blockade of PTP1B activity in IR lEVs fully restored IRS1 and AKT phosphorylation in adipocytes and blunted insulin-induced AKT phosphorylation by inhibition of macrophage secretome in hepatocytes. Conversely, blockade of PP2A activity in IR sEVs completely prevented insulin resistance in adipocytes and hepatocytes.
Conclusions: These data demonstrate that inhibition of phosphatases carried by EVs from IR patients rescues insulin signalling in adipocytes and hepatocytes and highlight PTP1B and PP2A carried by IR EVs as novel potential therapeutic targets against insulin resistance in adipose tissue and liver and the development of obesity.
| Original language | English |
|---|---|
| Pages (from-to) | 231-242 |
| Number of pages | 12 |
| Journal | Diabetologia |
| Volume | 68 |
| Early online date | 18 Oct 2024 |
| DOIs | |
| Publication status | Published - Jan 2025 |
Bibliographical note
We thank SCAHU staff of Angers University for taking care of animals, the SCIAM platform, especially Florence Manero, for technical assistance for electron microscopy imaging, and the staff of University Hospital Centre of Angers analysis of clinical data of NUMEVOX cohort. Also, we thank the Department of Pathology of University Hospital Centre of Angers for help on histological analysis.Data Availability Statement
All data generated or analysed during this study are available on request from the authorsFunding
This work was supported by Institut National de la Santé et de la Recherche Médicale, Université d’Angers, Centre Hospitalo-Universitaire d’Angers and Fondation de France [n°00096290]. SA was recipient of a doctoral fellowship from Conseil Départemental de Mayotte. XVG was supported by Fondation pour la Recherche Médicale [SPF201809006985].
| Funders | Funder number |
|---|---|
| Fondation pour la Recherche Médicale | SPF201809006985 |
| Fondation de France | n°00096290 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adipose tissue
- Extracellular vesicles
- Insulin resistance
- Liver
- Phosphatases
Fingerprint
Dive into the research topics of 'Circulating extracellular vesicle-carried PTP1B and PP2A phosphatases as regulators of insulin resistance'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS